For comments, suggestions
Created with Raphaël 2.1.0 14.11.2016 Filing date 28.07.2020 Validation fee payment 30.09.2020 (A1) Patent application published 21.10.2021 AGEPI application filing date 31.12.2021 (T2) Translation of the validated European patent 25.05.2025 14.11.2025 Valid until 15.11.2026 Renewal fee to be paid until 14.11.2036 Patent will expire on

Patent in force


(210)Number of the EPO application19205980
(220)Filing date of the EPO application2016.11.14
(80)EPO patent specification publication (B)EPB nr. 32/2021, 2021.08.11
(110)EPO patent number3620176
(11)Number of the documentMD 3620176 T2
(21)Number of the applicatione 2020 0899
(71)Name(s) of applicant(s), code of the countryCHIESI FARMACEUTICI S.P.A., IT;
(72)Name(s) of inventor(s), code of the countryCAFIERO Claudio, IT;
ORTENZI Leonardo, IT;
SCHIARETTI Francesca, IT;
(73)Name(s) of owner(s), code of the countryCHIESI FARMACEUTICI S.P.A., IT;
(54)Title of the inventionA process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
(13)Kind-of-document code T2
(51)International Patent Classification A61K 9/00 (2006.01.01); A61K 9/14 (2006.01.01); A61P 11/00 (2006.01.01); A61P 29/00 (2006.01.01); A61K 47/12 (2006.01.01); A61K 47/26 (2006.01.01); A61K 9/16 (2006.01.01); A61K 31/40 (2006.01.01); A61K 31/573 (2006.01.01); A61K 45/06 (2006.01.01); A61K 31/167 (2006.01.01)
(19)CountryIT
(41)Date of publication of the application2020.09.30
(49)Date of publication of the translation of the validated European patent specification2021.12.31
(30)Priority15194660, 2015.11.16, EP
(74)Patent attorney(Procedură) SOCOLOVA Sofia, Str. Drumul Viilor nr. 42, bloc 3, ap. 60, MD-2021, Chişinău, Republica Moldova
Up
/Inventions/details/3620176